Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 921-930 of 11888

Edit search filters
  1. A Study to Demonstrate that Acetazolamide is not Inferior to Diazepam for Patients who have Continuous Spike and Wave Brain Pattern in Sleep

    Rochester, MN

  2. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Use of AliveCor ECG Monitoring to Replicate ECG Lead Recording

    Scottsdale/Phoenix, AZ

  4. Subharmonic Aided Pressure Estimation Of Portal Hypertension

    Rochester, MN

  5. Pragmatic Study Of Disparities In Chronic Disease Approach To Ameliorate Tobacco Related Cardiovascular Disease

    Rochester, MN

  6. A Study Comparing The Safety And Effectiveness Of Lonapegsomatropin With Placebo And Somatropin In Adults With Growth Hormone Deficiency

    Rochester, MN

  7. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma

    Rochester, MN

  9. A Study to Evaluate Molecular Mechanisms of Exercise Benefits in Insulin Resistant People

    Rochester, MN

  10. A Study to Analyze The Impact of Pharmacist Consultation in Patients Beginning Intravenous Cancer Treatment

    La Crosse, WI

.

Mayo Clinic Footer